These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 29703243)

  • 21. A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018.
    Dan-Nwafor CC; Ipadeola O; Smout E; Ilori E; Adeyemo A; Umeokonkwo C; Nwidi D; Nwachukwu W; Ukponu W; Omabe E; Anaebonam U; Igwenyi N; Igbodo G; Eteng W; Uzoma I; Saleh M; Agboeze J; Mutbam S; de Gooyer T; Short R; Aniaku E; Onoh R; Ogah E; Nguku P; Oladejo J; Peter C; Ojo O; Ihekweazu C
    Int J Infect Dis; 2019 Jun; 83():88-94. PubMed ID: 30930184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological trends of Lassa fever in Nigeria from 2015-2021: A review.
    Grace JA; Egoh IJ; Udensi N
    Ther Adv Infect Dis; 2021; 8():20499361211058252. PubMed ID: 34868582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.
    Yaro CA; Kogi E; Opara KN; Batiha GE; Baty RS; Albrakati A; Altalbawy FMA; Etuh IU; Oni JP
    BMC Infect Dis; 2021 Feb; 21(1):149. PubMed ID: 33546623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying the seasonal drivers of transmission for Lassa fever in Nigeria.
    Akhmetzhanov AR; Asai Y; Nishiura H
    Philos Trans R Soc Lond B Biol Sci; 2019 Jun; 374(1775):20180268. PubMed ID: 31056054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geographical drivers and climate-linked dynamics of Lassa fever in Nigeria.
    Redding DW; Gibb R; Dan-Nwafor CC; Ilori EA; Yashe RU; Oladele SH; Amedu MO; Iniobong A; Attfield LA; Donnelly CA; Abubakar I; Jones KE; Ihekweazu C
    Nat Commun; 2021 Oct; 12(1):5759. PubMed ID: 34599162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The challenges of detecting and responding to a Lassa fever outbreak in an Ebola-affected setting.
    Hamblion EL; Raftery P; Wendland A; Dweh E; Williams GS; George RNC; Soro L; Katawera V; Clement P; Gasasira AN; Musa E; Nagbe TK
    Int J Infect Dis; 2018 Jan; 66():65-73. PubMed ID: 29138016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential for Seasonal Lassa Fever Case Exportation from Nigeria.
    Tuite AR; Watts AG; Kraemer MUG; Khan K; Bogoch II
    Am J Trop Med Hyg; 2019 Mar; 100(3):647-651. PubMed ID: 30693858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lassa virus RNA detection from suspected cases in Nigeria, 2011-2017.
    Babalola SO; Babatunde JA; Remilekun OM; Amaobichukwu AR; Abiodun AM; Jide I; Adeshina AI; Chikwe I; Aremu OS
    Pan Afr Med J; 2019; 34():76. PubMed ID: 31819792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lassa fever outbreaks in Nigeria.
    Akpede GO; Asogun DA; Okogbenin SA; Okokhere PO
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):663-666. PubMed ID: 30111178
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk maps of Lassa fever in West Africa.
    Fichet-Calvet E; Rogers DJ
    PLoS Negl Trop Dis; 2009; 3(3):e388. PubMed ID: 19255625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventive practices by households against Lassa fever transmission in Ondo State, Southwest, Nigeria.
    Isere EE; Fatiregun AA; Omorogbe NE; Oluwole MT
    Pan Afr Med J; 2022; 43():176. PubMed ID: 36879638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic modelling of the large-scale Lassa fever epidemics in Nigeria from 2016 to 2019.
    Musa SS; Zhao S; Gao D; Lin Q; Chowell G; He D
    J Theor Biol; 2020 May; 493():110209. PubMed ID: 32097608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outbreak of lassa fever in Nigeria: measures for prevention and control.
    Mofolorunsho KC
    Pan Afr Med J; 2016; 23():210. PubMed ID: 27347299
    [No Abstract]   [Full Text] [Related]  

  • 34. Lassa fever in West African sub-region: an overview.
    Ogbu O; Ajuluchukwu E; Uneke CJ
    J Vector Borne Dis; 2007 Mar; 44(1):1-11. PubMed ID: 17378212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of a cross-border case of Lassa fever in West Africa.
    Keïta M; Kizerbo GA; Subissi L; Traoré FA; Doré A; Camara MF; Barry A; Pallawo R; Baldé MO; Magassouba N; Djingarey MH; Fall IS
    BMC Infect Dis; 2019 Jul; 19(1):606. PubMed ID: 31291900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inter-State Transmission of Lassa Fever during the 2015-2016 Lassa Outbreak in Nigeria: An Implication for Infection Prevention and Control Practices.
    Mohammed Y; Bello UI; Chinaka CC; Onuoha M; Sarki M; Yahaya SS; Suleiman K; Dalhat MM
    West Afr J Med; 2023 Jul; 40(7):684-688. PubMed ID: 37515581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
    Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge, Misperceptions, Preparedness, and Barriers towards Lassa Fever Control among Health Care Workers in a Tertiary Institution in Enugu, Nigeria.
    Ndu AC; Kassy WC; Ochie CN; Arinze-Onyia SU; Okeke TA; Aguwa EN; Okwor TJ; Chinawa A
    J Health Care Poor Underserved; 2019; 30(3):1151-1164. PubMed ID: 31422994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New methodologies for the estimation of population vulnerability to diseases: a case study of Lassa fever and Ebola in Nigeria and Sierra Leone.
    Kajero O; Del Rio Vilas V; Wood JLN; Lo Iacono G
    Philos Trans R Soc Lond B Biol Sci; 2019 Jul; 374(1776):20180265. PubMed ID: 31104602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.